Nifty trades above 25,950 mark; pharma shares rally

Image
Last Updated : Dec 19 2025 | 10:50 AM IST
The key equity benchmarks traded with modest gains in morning trade, snapping a four-day losing streak. The Nifty traded above the 25,950 mark, supported by a strengthening rupee against the US dollar and the signing of the IndiaOman Free Trade Agreement, which provided additional support to market sentiment.

Meanwhile, pharma stocks advanced after declining in the past trading session.

At 10:30 ST, the barometer index, the S&P BSE Sensex, jumped 494.72 points or 0.59% to 84,971.12. The Nifty 50 index advanced 148.56 points or 0.58% to 25,964.10.

In the broader market, the S&P BSE Mid-Cap index rose 0.36% and the S&P BSE Small-Cap index rallied 0.65%.

The market breadth was strong. On the BSE, 2,381 shares rose and 1,173 shares fell. A total of 260 shares were unchanged.

New Listing:

Shares of ICICI Prudential Asset Management Company were currently trading at Rs 2,615.90 at 10:09 IST on the BSE, representing a premium of 20.83% as compared with the issue price of Rs 2,165.

The stock debuted at Rs 2,606.20 on the BSE, exhibiting a premium of 20.38% over the issue price.

So far, the stock has hit a high of 2,662 and a low of 2,602. On the BSE, over 21.49 lakh shares of the company were traded in the counter so far.

Buzzing Index:

The Nifty Pharma index jumped 1.02% to 22,787.30. The index slipped 0.24% in the past trading session.

Wockhardt (up 7.32%), Divis Laboratories (up 3.01%), Laurus Labs (up 2.86%), Ajanta Pharma (up 2.71%), Piramal Pharma (up 1.96%), Biocon (up 1.92%), Gland Pharma (up 1.24%), Ipca Laboratories (up 1.22%), Aurobindo Pharma (up 1.21%) and Glenmark Pharmaceuticals (up 1.1%) advanced.

Stocks in Spotlight:

Apollo Micro Systems added 1.10% to Rs 229.05 after the company said that its subsidiary IDL Explosives has received industrial license for manufacturing of widely used explosives HMX and TNT.

Aeroflex Industries surged 10.11% after the companys board has approved raising funds through a preferential issue of 30.10 lakh equity shares at an issue price of Rs 182.70 per share (including premium) to non-promoters.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 19 2025 | 10:37 AM IST

Next Story